The Bombay high court upheld the arbitral award allowing monetary claims of agriculture business tycoon Mahyco Monsanto Biotech Ltd Versus Nuziveedu Seeds Ltd, comprising Justice CCI and the Arbitral tribunal are not the same and are very distinct in nature. The arbitral award passed in January 2019 was challenged by Nuziveedu and its associate primarily on the ground that the tribunal could not have adjudicated the matter when the Competition Commission of India (CCI) concerning the use of Bt cotton Seeds.

The petitioner and the respondent signed a Sub- License Agreement (SLA) on 20th January 2004. Like they mentioned in the agreement the Respondent gave 50 cotton seeds of transgenic variety with bt. Traits to produce new varieties of cotton seeds by the petitioner, and the right to sell cotton hybrid seeds agreement for 10 years. The petitioner stated that according to the terms of agreement the respondent was required to pay the amount on every 450gm packet of Bt. cotton seeds. The respondent has paid only 50 lakhs in this regards. However the respondent filed a petition under section-9 of the Arbitration Act for depositing the amount against the petitioner as per the terms of the SLA, 2015.

The petitioner stated that for the refund of the excess trait value that was paid from 2010 to 2014. The government of India filed a reference before the Competition Commission of India for investigation and taking appropriate action against the respondent for defying the provision of Competition Act. The Respondent invoked the Arbitration Agreement for settling the issue by way of Arbitration and nominated a former Judge of the Supreme Court as it’s the nominal arbitrator. A former Judge of the Supreme Court was appointed as the presiding arbitrator. The Petitioner filed an application under Section- 16 of the Arbitration Act praying for the dismissal of the claims made by the Respondent. The Arbitral Tribunal dismissed the application filed by the Petitioner.

It was observed by the Court the Arbitral Tribunal only allowed the monetary claims made by the Respondent. It was stated that” the tribunal rightly held that the adjudication by the tribunal shall be in the nature of the right and liability of the parties to the agreement and would relate to right in personam and not right in rem. In the proceedings before the CCI, whatever may be the outcome, the respondent would not be able to get any effective relief or decree or award directing the petitioner herein to pay the particular amount to the respondent. It was rightly held by the Arbitral Tribunal that the respondent had certain rights under the 2015 SLA and thus it must also have a remedy for enforcement of such rights.” It was held that the since the petitioner had raised an issue that the 2015 SLA was void or that the respondent had abused the dominant position and those issues could be decided only by the CCI, it would not preclude the arbitral tribunal from deciding the monetary claims made before it which were not within the jurisdiction of the CCI.

For Ref- https://www.latestlaws.com/latest-news/mahyco-monsanto-biotech-receives-the-arbitral-award-against-nuziveedu-seeds-ltd-read-judgment/




This website has been designed only for the purposes of dissemination of basic information on KOVE GLOBAL; information which is otherwise available on the internet, various public platforms and social media. Careful attention has been given to ensure that the information provided herein is accurate and up-to-date. However, KOVE GLOBAL is not responsible for any reliance that a reader places on such information and shall not be liable for any loss or damage caused due to any inaccuracy in or exclusion of any information, or its interpretation thereof. Reader is advised to confirm the veracity of the same from independent and expert sources.

This website is not an attempt to advertise or solicit clients, and does not seek to create or invite any lawyer-client relationship. The links provided on this website are to facilitate access to basic information on KOVE GLOBAL, and, to share the various thought leadership initiatives undertaken by it. The content herein or on such links should not be construed as a legal reference or legal advice. Readers are advised not to act on any information contained herein or on the links and should refer to legal counsels and experts in their respective jurisdictions for further information and to determine its impact.

KOVE GLOBAL advises against the use of the communication platform provided on this website for exchange of any confidential, business or politically sensitive information. User is requested to use his or her judgment and exchange of any such information shall be solely at the user’s risk.